SCHEMBL312816

SCHEMBL312816

CCc1ccc(N)nc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30279718 1.00 — —
SCHEMBL10264595 0.85 SMN1; SMN2 (0.58) —
SCHEMBL13484223 0.83 PIK3CD (0.52) —
SCHEMBL294092 0.82 GABRP (0.50) —
SCHEMBL4154226 0.79 NFKB1 (0.54) —
SCHEMBL29911003 0.78 — —
SCHEMBL318570 0.78 — —
SCHEMBL10723761 0.77 RAB9A (0.54) —
SCHEMBL14535423 0.77 GABRP (0.46) —
SCHEMBL1126370 0.77 HRH3 (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 319 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119432148-A Perovskite ink, perovskite film and battery device 云南大学 2025-02-14 — — CN claimed
EP-2262501-A2 TREATMENT OF SEPSIS WITH 5-ETHYL-1-PHENYL-2(1H)-PYRIDONE AND NOVEL METHODS FOR SYNTHESIS Solanan, Inc. (US) 2010-12-22 — — EP claimed
WO-2009111785-A2 TREATMENT OF SEPSIS WITH 5-ETHYL-1-PHENYL-2(1H)-PYRIDONE AND NOVEL METHODS FOR SYNTHESIS SOLANAN, INC. (US) 2009-09-11 — — WO claimed
WO-2003013523-A1 SH3 PROTEIN DOMAINS AND THEIR LIGANDS ADELAIDE RESEARCH & INNOVATION PTY LTD (AU) 2003-02-20 — — WO claimed
US-5972975-A Substituted 2-aminopyridines as inhibitors of nitric oxide synthase MERCK & CO., INC. (US) 1999-10-26 — — US claimed
US-12384773-B2 Thiazole compounds and methods of use thereof ARCUS BIOSCIENCES, INC. (US) 2025-08-12 — — US disclosed
WO-2025096979-A1 THIAZOLE COMPOUNDS AS KIT INHIBITORS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2025-05-08 — — WO disclosed
US-20250145606-A1 THIAZOLE COMPOUNDS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2025-05-08 — — US disclosed
CN-119432148-A Perovskite ink, perovskite film and battery device 云南大学 2025-02-14 — — CN disclosed
US-20240239764-A1 SUBSTITUTED AMINOBENZYL HETEROARYL COMPOUNDS AS EGFR AND/OR PI3K INHIBITORS THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2024-07-18 — — US disclosed
US-12030853-B2 MASP-2 inhibitors and methods of use OMEROS CORPORATION (US) 2024-07-09 — — US disclosed
CN-117800904-A ROR gamma inhibitors containing sulfonyl structures 正大天晴药业集团股份有限公司 2024-04-02 — — CN disclosed
EP-0333185-A2 Cyan dye-forming coupler and silver halide photosensitive material containing the same FUJI PHOTO FILM CO., LTD. (JP) 1989-09-20 — — EP disclosed
US-4619997-A Substituted 2-pyridylmethylthio and sulfinyl-benzimidazoles as gastric antisecretory agents THE UPJOHN COMPANY (US) 1986-10-28 — — US disclosed
US-4575554-A CYTOPROTECTIVE THE UPJOHN COMPANY (US) 1986-03-11 — — US disclosed
EP-0098684-A2 Modified chichibabin reaction, and novel pyridine derivatives REILLY INDUSTRIES, INC. (US) 1984-01-18 — — EP disclosed
US-4386209-A Chichibabin reaction REILLY TAR & CHEMICAL CORPORATION (US) 1983-05-31 — — US disclosed
US-4192944-A ANTIANAPHYLACTIC BRISTOL-MYERS COMPANY (US) 1980-03-11 — — US disclosed
US-4122274-A ANTIALLERGY BRISTOL-MYERS COMPANY (US) 1978-10-24 — — US disclosed
US-4039550-A ANTHELMINTIC AGENTS STERLING DRUG INC. (US) 1977-08-02 — — US disclosed
Send feedback